DrugPatentWatch Database Preview
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic drug sources for hydrochlorothiazide; spironolactone and what is the scope of hydrochlorothiazide; spironolactone patent protection?
Hydrochlorothiazide; spironolactone
is the generic ingredient in three branded drugs marketed by Gd Searle Llc, Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Yaopharma Co Ltd, Ivax Pharms, Lederle, Parke Davis, Upsher Smith, Usl Pharma, and Vangard, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are thirty-two drug master file entries for hydrochlorothiazide; spironolactone. Five suppliers are listed for this compound.
Summary for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 15 |
| NDAs: | 18 |
| Drug Master File Entries: | 32 |
| Suppliers / Packagers: | 5 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 6 |
| Patent Applications: | 28 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE at DailyMed |
Pharmacology for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
| Ingredient-type | Thiazides |
| Drug Class | Aldosterone Antagonist Thiazide Diuretic |
| Mechanism of Action | Aldosterone Antagonists |
| Physiological Effect | Increased Diuresis |
Synonyms for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
| C24H32O4S.C7H8ClN3O4S2 |
| Hydrochlorothiazide / Spironolactone |
| LS-178649 |
| MP 40 [Pill Imprint] |
| SCHEMBL930086 |
| Spiridazide |
| SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE |
| SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE |
| Spironolactone-hydrochlorothiazide |
| Spironothiazid |
| Uractazide |
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087651-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Lederle | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087511-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Watson Labs | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087398-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: